Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases. 

Biotechnology

Q32 Bio

Q32 Bio's headquarters in Cambridge, MA, United States

This department is responsible for advancing scientific research and overseeing the development of new products.

Research and Development

This department oversees organizational strategy and decision-making processes.

Leadership

The Scientific Research & Development team at Q32 Bio is dedicated to advancing innovative therapies that target key regulators of the immune system. Comprising experts in pharmacology, protein science, and translational biology, the team collaborates to design and execute preclinical studies, develop cutting-edge biologics, and navigate regulatory processes. Their goal is to translate scientific discoveries into effective treatments for autoimmune and inflammatory diseases.

Scientific Research & Development

This department manages employee relations, organizational culture, and personnel administration to support the overall workforce.

Human Resources Operations

This department manages financial transactions, reporting, and auditing for the organization.

Accounting Services

The Clinical Operations team at Q32 Bio is responsible for the planning, implementation, and management of clinical trials that evaluate the safety and efficacy of innovative immunotherapies. This team ensures compliance with regulatory standards, oversees study protocols, coordinates with clinical sites, and collects and analyzes trial data to support the advancement of therapies aimed at re-balancing the immune system in patients with severe autoimmune and inflammatory diseases.

People (4)

Jobs (0)

Other teams

Leadership

Scientific Research & Development

Human Resources Operations

Accounting Services

Clinical Operations